{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:22:23Z","timestamp":1776378143290,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1124\/jpet.102.045278","type":"journal-article","created":{"date-parts":[[2003,2,27]],"date-time":"2003-02-27T18:31:38Z","timestamp":1046370698000},"page":"1172-1180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Modulatory Effect of Bolinaquinone, a Marine Sesquiterpenoid, on Acute and Chronic Inflammatory Processes"],"prefix":"10.1016","volume":"304","author":[{"given":"Rut","family":"Lucas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clelia","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Valeria","family":"D\u2019auria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Pay\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.045278_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<245::AID-IJC2>3.0.CO;2-Z","article-title":"Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer.","volume":"74","author":"Abe","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.102.045278_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bbrc.1995.1378","article-title":"Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages.","volume":"208","author":"Arias-Negrete","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.102.045278_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.39.1.175","article-title":"Regulation and inhibition of phospholipase A2.","volume":"39","author":"Balsinde","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.102.045278_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2760(95)00023-6","article-title":"Differential regulation of elicited-peritoneal macrophage 14 kDa and 85 kDa phospholipase A2(s) by transforming growth factor-\u03b2.","volume":"1256","author":"Bolognese","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.102.045278_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/art.1780360208","article-title":"Phospholipase A2 and arthritis.","volume":"36","author":"Bomalaski","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.102.045278_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00233250","article-title":"A study of the novel anti-inflammatory agent florifenine. Topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions.","volume":"351","author":"Bustos","year":"1995","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/jpet.102.045278_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01966592","article-title":"Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.","volume":"17","author":"Carlson","year":"1985","journal-title":"Agents Actions"},{"key":"10.1124\/jpet.102.045278_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(94)00672-T","article-title":"Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase.","volume":"273","author":"Connor","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.045278_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.1711340205","article-title":"The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system.","volume":"134","author":"Edwards","year":"1981","journal-title":"J Pathol"},{"key":"10.1124\/jpet.102.045278_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis.","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.102.045278_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(94)90759-5","article-title":"Avarol and avarone, two new anti-inflammatory agents of marine origin.","volume":"253","author":"Ferr\u00e1ndiz","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.045278_bib12","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.152.11.5438","article-title":"Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells.","volume":"152","author":"Fonteh","year":"1994","journal-title":"J Immunol"},{"key":"10.1124\/jpet.102.045278_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.bi.63.070194.002123","article-title":"5-Lipoxygenase.","volume":"63","author":"Ford-Hutchinson","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/jpet.102.045278_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2571(97)00002-2","article-title":"Regulation of secretory type-II phospholipase A2 and of lysophosphatidic acid synthesis.","volume":"38","author":"Fourcade","year":"1998","journal-title":"Adv Enzyme Regul"},{"key":"10.1124\/jpet.102.045278_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0022-2275(20)36786-9","article-title":"Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules.","volume":"15","author":"Franson","year":"1974","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.102.045278_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjp.0702302","article-title":"Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.","volume":"126","author":"Garcia-Pastor","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.045278_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0022-3565(24)38119-4","article-title":"Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.","volume":"289","author":"Garcia-Pastor","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.045278_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/np000637w","article-title":"New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.","volume":"64","author":"Giannini","year":"2001","journal-title":"J Nat Prod"},{"key":"10.1124\/jpet.102.045278_bib19","doi-asserted-by":"crossref","first-page":"25722","DOI":"10.1016\/S0021-9258(18)35667-9","article-title":"Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle.","volume":"267","author":"Gross","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.045278_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0076-6879(94)34115-X","article-title":"Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase.","volume":"234","author":"Hoult","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.102.045278_bib21","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI119353","article-title":"Posttranscriptional effect of insulin like growth factor I on interleukin 1\u03b2 induced type II secreted phospholipase A2 gene expression in rabbit articular chondrocytes.","volume":"99","author":"Jacques","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.102.045278_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/rheumatology\/35.8.711","article-title":"Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis.","volume":"35","author":"Kang","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1124\/jpet.102.045278_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-5793(94)00722-5","article-title":"Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients.","volume":"350","author":"Kaur","year":"1994","journal-title":"FEBS Lett"},{"issue":"Suppl 1","key":"10.1124\/jpet.102.045278_bib24","doi-asserted-by":"crossref","first-page":"I32","DOI":"10.1136\/ard.58.2008.i32","article-title":"The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.","volume":"58","author":"Kollias","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/jpet.102.045278_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/eji.1830250414","article-title":"Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages.","volume":"25","author":"Marcinkiewicz","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.102.045278_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0165-6147(92)90100-K","article-title":"Designing therapeutically effective 5-lipoxygenase inhibitors.","volume":"13","author":"McMillan","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.045278_bib27","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/gut.35.11.1593","article-title":"Increased group II phospholipase A2 in colonic mucosa of patients with Crohn\u2019s disease and ulcerative colitis.","volume":"35","author":"Minami","year":"1994","journal-title":"Gut"},{"key":"10.1124\/jpet.102.045278_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/abio.1993.1449","article-title":"A fluorometric assay for the measurement of nitrite in biological samples.","volume":"214","author":"Misko","year":"1993","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.102.045278_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-5793(90)80986-S","article-title":"Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2.","volume":"268","author":"Murakami","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.102.045278_bib30","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.1996.tb15353.x","article-title":"Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation.","volume":"117","author":"Pay\u00e1","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.045278_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0192-0561(95)00030-6","article-title":"Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion.","volume":"17","author":"Pennanen","year":"1995","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/jpet.102.045278_bib32","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1172\/JCI116860","article-title":"Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.","volume":"92","author":"Pfeilschifter","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.102.045278_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1525-1381.1999.t01-1-99231.x","article-title":"The biology of 5-lipoxygenase: function, structure and regulatory mechanisms.","volume":"111","author":"Silverman","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1124\/jpet.102.045278_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/0929867306666220320223452","article-title":"Manoalide.","volume":"6","author":"Soriente","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.102.045278_bib35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/art.1780360803","article-title":"Nitric oxide and arthritis.","volume":"36","author":"Stefanovic-Racic","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.102.045278_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1248\/bpb1978.4.565","article-title":"Anti-inflammatory testing methods: comparative evaluation of mice and rats.","volume":"4","author":"Sugishita","year":"1981","journal-title":"J Pharmacobio-Dynam"},{"key":"10.1124\/jpet.102.045278_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1476-5381.1988.tb11557.x","article-title":"Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.","volume":"94","author":"Tateson","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.045278_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0076-6879(88)62089-1","article-title":"Adjuvant arthritis.","volume":"162","author":"Taurog","year":"1988","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.102.045278_bib39","first-page":"391","article-title":"Biology of disease. Role of secretory phospholipases A2 in the pathobiology of disease.","volume":"55","author":"Vadas","year":"1986","journal-title":"Lab Invest"},{"key":"10.1124\/jpet.102.045278_bib40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.1780120503","article-title":"Comparative bioassay of drugs in adjuvant-induced arthritis in rats: flufenamic acid, mefenamic acid and phenylbutazone.","volume":"12","author":"Winder","year":"1969","journal-title":"Arthritis Rheum"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524362172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524362172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.045278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:39:48Z","timestamp":1740008388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524362172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0022356524362172"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.045278","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulatory Effect of Bolinaquinone, a Marine Sesquiterpenoid, on Acute and Chronic Inflammatory Processes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.045278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}